Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ala”

271 pharma patents match "ala" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 271
Index total 30,257
Page 9 / 12

Quick answer

This filtered view shows 271 pharmaceutical patents matching "ala" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

271 results for “ala” · 30,257 patents in full index Clear search

  1. US 8367734

    Stable epinephrine suspension formulation with high inhalation delivery efficiency

    Amphastar Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  2. US 8367638

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  3. US 8323670

    Topical compositions of opioid antagonists and methods for treating skin conditions therewith

    Ak Kimya Ithalat-Ihracat Ve Sanayii A.S. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  4. US 8283370

    Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use

    The United States of America as represented by the Secretary of the Army · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  5. US 8278246

    Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted

  6. US 8236780

    Galactose—pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  7. US 8232255

    Methods for vaccinating against malaria

    United States of America as represented by the Secretary of the Air Force · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted

  8. US 8183358

    Puumala virus full-length M segment-based DNA vaccines

    The United States of America as represented by the Secretary of the Army · Granted May 22, 2012 · Expires May 17, 2032

    granted

  9. US 8153116

    Use of conditional plasmodium strains lacking an essential gene in malaria vaccination

    UNIVERSITY OF CONNECTICUT · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  10. US 8128921

    Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination

    UNIVERSITY OF CONNECTICUT · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted

  11. US 8124653

    Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia

    The Board of Regents of the University of Texas System · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  12. US 8039008

    Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis

    The Board of Regents of the University of Texas System · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  13. US 8012493

    Malaria vaccines

    The United States of America as represented by the Secretary of the Army · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  14. US 8012976

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  15. US 7972821

    Production of functional proteins: balance of shear stress and gravity

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  16. CA 2760180

    COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES A MEDIATION PAR MCP-1

    ACRAF [IT] · Granted Mar 31, 2011 · Expires Mar 26, 2031

    granted

  17. US 2011062165

    BALANCED INDIVIDUAL DINING PLATE

    ALLERGAN INC [US] · Granted Mar 17, 2011 · Expires Mar 12, 2031

    granted

  18. US 7906555

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  19. US 7897763

    Process for the preparation of substituted phenylalanines

    LEXICON PHARMACEUTICALS, INC. · Granted Mar 1, 2011 · Expires Feb 24, 2031

    granted

  20. US 7855291

    Process for the preparation of substituted phenylalanines

    LEXICON PHARMACEUTICALS, INC. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

  21. US 7790433

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  22. CA 2742910

    THERAPIE DE COMBINAISON COMPRENANT UN INHIBITEUR DE DHODH ET DU METHOTREXATE POUR TRAITER UNE MALADIE AUTO-IMMUNE

    4SC AG [DE] · Granted May 14, 2010 · Expires May 9, 2030

    granted

  23. US 7662607

    Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

    New Century Pharmaceuticals, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  24. US 7655247

    Malaria vaccines

    The Government of the United States, as Respresented by the Secretary of the Army · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.